GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT Jayamas Medica Industri Tbk (ISX:OMED) » Definitions » Net Cash per Share

PT Jayamas Medica Industri Tbk (ISX:OMED) Net Cash per Share : Rp30.67 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PT Jayamas Medica Industri Tbk Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). PT Jayamas Medica Industri Tbk's Net Cash per Share for the quarter that ended in Mar. 2024 was Rp30.67.

The historical rank and industry rank for PT Jayamas Medica Industri Tbk's Net Cash per Share or its related term are showing as below:

ISX:OMED' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 6.42   Med: 6.85   Max: 7.61
Current: 6.59

During the past 5 years, the highest Price-to-Net-Cash Ratio of PT Jayamas Medica Industri Tbk was 7.61. The lowest was 6.42. And the median was 6.85.

ISX:OMED's Price-to-Net-Cash is ranked better than
51.9% of 316 companies
in the Medical Devices & Instruments industry
Industry Median: 6.93 vs ISX:OMED: 6.59

PT Jayamas Medica Industri Tbk Net Cash per Share Historical Data

The historical data trend for PT Jayamas Medica Industri Tbk's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Jayamas Medica Industri Tbk Net Cash per Share Chart

PT Jayamas Medica Industri Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
7.97 8.10 12.41 32.06 30.34

PT Jayamas Medica Industri Tbk Quarterly Data
Dec19 Dec20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.84 24.45 27.03 30.34 30.67

Competitive Comparison of PT Jayamas Medica Industri Tbk's Net Cash per Share

For the Medical Instruments & Supplies subindustry, PT Jayamas Medica Industri Tbk's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Jayamas Medica Industri Tbk's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT Jayamas Medica Industri Tbk's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where PT Jayamas Medica Industri Tbk's Price-to-Net-Cash falls into.



PT Jayamas Medica Industri Tbk Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

PT Jayamas Medica Industri Tbk's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1184218.036-336074.636-27188.848)/27058.8
=30.34

PT Jayamas Medica Industri Tbk's Net Cash per Share for the quarter that ended in Mar. 2024 is calculated as

Net Cash per Share (Q: Mar. 2024 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1194650.153-337020.694-27810.471)/27058.8
=30.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Jayamas Medica Industri Tbk  (ISX:OMED) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


PT Jayamas Medica Industri Tbk Net Cash per Share Related Terms

Thank you for viewing the detailed overview of PT Jayamas Medica Industri Tbk's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Jayamas Medica Industri Tbk (ISX:OMED) Business Description

Traded in Other Exchanges
N/A
Address
Sebelah Selatan Jalan By Pass RT 05 / RW 01, Kelurahan Sidomojo, Kecamatan Krian, Sidoarjo, Jawa Timur, East Java, IDN, 61262
PT Jayamas Medica Industri Tbk is engaged in the business of manufacturing medical devices and other household health supplies. It initially began with the manufacture of urine bags, OneMed later expanded in the manufacturing business of medical equipment and supplies in Indonesia with a range of variants of products manufactured locally. The Company and its Subsidiaries has three main divisions: Manufacturing; Distribution and Retail.